At a glance

ClinicalIndex Comparison Record

Phase 4Completed· 360 enrolled

Drug / intervention

Sirolimus-eluting stent (Cypher) +1 moredevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00146575

NCT00146575Phase 4Completed

Compare CT.gov

Randomized Trial of Paclitaxel-Eluting Stent and Sirolimus-Eluting Stent for Restenosis Reduction in Small Coronary Vessels (ISAR-SMART-3)

Deutsches Herzzentrum Muenchen·interventional·Posted Sep 7, 2005·Updated Jan 11, 2008

In Brief

A Phase 4 clinical trial evaluating Sirolimus-eluting stent (Cypher) and Paclitaxel-eluting stent (Taxus) for Coronary Disease. Completed, enrolled 360 participants across 2 sites.

Detailed Summary

The purpose of this study is to compare the efficacy of paclitaxel- and sirolimus-eluting stents to prevent re-blockage of small coronary arteries

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsCoronary Disease

CountriesGermany

Collaborators--

Timeline

Phase 4CompletedFinished

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartJun 2003

Study CompletionFeb 2005

First PostedSep 2005

TodayJul 2026

First PostedSep 7, 2005

Enrollment StartJun 1, 2003

Study CompletionFeb 1, 2005

TodayJul 1, 2026

Posted 20.8 years ago

Interventions

Sirolimus-eluting stent (Cypher)device

patients have been implanted a Cypher stent

Paclitaxel-eluting stent (Taxus)device

patients have been implanted a Taxus stent